GlassScriptPhysician profile
Shelly K Thompson
NPI 1811108566
$1,173.57
in general payments reported to CMS, 2019-2025
16 companies · $250 in 2025
The $250 reported for 2025 was more than what 80% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.50 · 2020: $69.71 · 2021: $216 · 2022: $156 · 2023: $202 · 2024: $198 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $370.20 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $154.03 | 2021-2025 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $127.90 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Ironshore Pharmaceuticals INC. | $107.30 | 2019-2024 | |
| Pfizer INC. | $97.79 | 2019-2021 | |
| Organon LLC | $92.07 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $34.12 | 2019-2020 | |
| Hologic Sales and Service, LLC | $32.22 | 2023 | Affirm Prone Biopsy System |
| Sanofi Pasteur INC. | $29.76 | 2021-2025 | |
| Global Blood Therapeutics, INC. | $27.03 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $23.85 | 2025 | Zoryve |
| Astrazeneca Pharmaceuticals LP | $18.39 | 2023 | Flumist Quadrivalent |
| Seqirus USA INC | $15.67 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.33 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.33 | 2025 | Jornay Pm |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $13.58 | 2023 | Daybue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelly Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.